Biologic Excipients Market Trends 2022| Segmentation, Outlook, Industry Report & Analysis to 2022-2028
Future Market Insights (FMI) delivers key insights on the
global biologic excipients market in its upcoming report
titled “Biologic Excipients Market: Global Industry Analysis 2013–2021 and
Opportunity Assessment 2022 – 2028”. In terms of revenue, the global biologic
excipients market is projected to register a CAGR of 3.4% over the forecast
period owing to various factors, regarding which FMI offers detailed insights
and forecasts in this report.
Global Biologic Excipients Market: Segmental Analysis
& Forecast
The global market is segmented based on excipient type, end
user and region. Based on excipient type the market is segmented into polymers,
sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and
others. Polymers biologic excipients are anticipated to lead the biologic
excipients market over the forecast period. Polymer biologic excipients account
for the highest revenue share and are anticipated to witness a growth rate of
3.7% over the forecast period.
Ask for the Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-6982
By end user, the market is segmented into biopharmaceutical
manufacturers, contract research organisations/contract manufacturing
organisations, and research organisations. Biopharmaceutical manufacturers is
the leading segment in the global biologic excipients market over the forecast
period. This segment accounts for a relatively higher revenue share, which is
expected to register a CAGR of 6.0% over the forecast period.
Global Biologic Excipients Market: Dynamics
Growth of the global biologic excipients market is primarily
driven by rising global demand for medicines, greater uptake of biologics
driving demand for parenteral formulations, increasing acquisition of contract
research organisations, patent expiration of major blockbuster drugs, growing
adoption of advanced drug delivery technologies, increasing research in
pediatric formulations, growing demand for extended-release or sustained
release formulations, increasing demand for oral solid drug formulations,
rising demand from emerging economies pushing local drug production, and
increasing per capita healthcare expenditure.
However, lack of proper data documentation on gras status of
excipients, regulatory audits restricting supply capacity, regulatory hurdles
detering novel excipient development, and stability testing of excipients
imposing cost liabilities on drug manufacturers are some factors expected to
hamper the growth of the global biologic excipients market over the forecast
period.
A key trend witnessed in the biologic excipients market is
increasing adoption of continuous processing of biologic excipients, dependence
of large drug manufacturers on in-house biologic excipients production, vast
proportion of imported excipients leading to production delays, and regulatory
harmonisation with respect to gradation of excipients. Furthermore, the growing
importance of developing biologic excipients by big players in order to enhance
their product portfolio, growing importance for manufacturing authorisation,
growing market for topical and parenteral applications and compulsory licensing
promoting demand for biologic excipients are the key trends likely to be
witnessed in the global biologic excipients market.
Global Biologic Excipients Market: Regional Analysis
The North America regional market is projected to dominate
the global biologic excipients market, accounting for a maximum revenue share
of the global market by 2021 end. The North America, Western Europe, and Asia
Pacific markets accounted for 77.3% of the total biologic excipients market
share in terms of value in 2021. Revenue from the market in APEJ is estimated
to expand at a CAGR of 4.2% over the forecast period.
Some of the key players featured in this report on the
global biologic excipients market include BASF Corporation, FMC Corporation,
Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc.,
Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company,
Colorcon Inc., Signet Chemical Co. Pvt. Ltd. This report discusses the
individual strategies followed by these companies regarding bringing
improvements in their products, creating new manufacturing facilities, market
consolidation and advanced R&D initiatives. The report concludes with key
takeaways for players already present in the market and new players planning to
enter the market.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government,
investors, and associated audiences in the healthcare sector to
identify and accentuate vital aspects applicable to product strategy,
regulatory landscape, technology evolution, and other crucial issues to achieve
sustainable success. Our unique approach to gathering market intelligence
equips you in devising innovation-driven trajectories for your business. Know
more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and
consulting services, serving clients in over 150 countries. FMI is
headquartered in Dubai, and has delivery centers in the UK, U.S. and India.
FMI’s latest market research reports and industry analysis help
businesses navigate challenges and make critical decisions with confidence and
clarity amidst breakneck competition. Our customized and syndicated market
research reports deliver actionable insights that drive sustainable growth.
A team of expert-led analysts at FMI continuously tracks emerging trends and
events in a broad range of industries to ensure that our clients prepare for
the evolving needs of their consumers.
Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Comments
Post a Comment